Last reviewed · How we verify
recombinant HIV-1 Tat protein
recombinant HIV-1 Tat protein is a Biologic drug developed by Istituto Superiore di Sanità. It is currently in Phase 1 development.
At a glance
| Generic name | recombinant HIV-1 Tat protein |
|---|---|
| Sponsor | Istituto Superiore di Sanità |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Therapeutic Vaccine for HIV (PHASE1)
- A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers (PHASE2)
- Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (PHASE2)
- A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002) (PHASE1)
- Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT
- Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS (PHASE1)
- Observational Study of the Preventive Trial With HIV-1 Tat Protein
- Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- recombinant HIV-1 Tat protein CI brief — competitive landscape report
- recombinant HIV-1 Tat protein updates RSS · CI watch RSS
- Istituto Superiore di Sanità portfolio CI
Frequently asked questions about recombinant HIV-1 Tat protein
What is recombinant HIV-1 Tat protein?
recombinant HIV-1 Tat protein is a Biologic drug developed by Istituto Superiore di Sanità.
Who makes recombinant HIV-1 Tat protein?
recombinant HIV-1 Tat protein is developed by Istituto Superiore di Sanità (see full Istituto Superiore di Sanità pipeline at /company/istituto-superiore-di-sanit).
What development phase is recombinant HIV-1 Tat protein in?
recombinant HIV-1 Tat protein is in Phase 1.
Related
- Manufacturer: Istituto Superiore di Sanità — full pipeline